logo
Share SHARE
FONT-SIZE Plus   Neg

Sucampo, Abbott Say Sucampo Pharma, Ltd. Gets Approval For AMITIZA In Japan

Sucampo Pharmaceuticals, Inc. (SCMP) and Abbott (ABT) announced that Sucampo Pharma, Ltd., a wholly owned subsidiary of Sucampo Pharmaceuticals, has received approval from the Ministry of Health, Labor and Welfare in Japan for AMITIZA (lubiprostone), a prescription medicine for the treatment of chronic constipation.

Sucampo submitted a marketing application to the Japanese Pharmaceuticals and Medical Devices Agency for approval to market AMITIZA in September 2010. The application included data from a Phase 3 efficacy trial in 124 Japanese patients as well as from a long-term open-label safety trial in 209 Japanese patients who received lubiprostone for up to 48 weeks. The application also included data from previous trials conducted in the United States, Canada and Europe.

"We are very pleased to receive Japan's first-ever approval for a prescription medicine for chronic constipation as it helps us achieve our objective of bringing medicines with novel mechanisms of action to patients with unmet medical needs on a global basis," said Ryuji Ueno, Sucampo's Chairman and Chief Executive Officer. "We look forward to working with Abbott to meet the needs of these patients in Japan."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Micro-blogging site Twitter Inc said Tuesday after the markets closed that its second quarter net loss narrowed from last year, as revenue surged 61%. The company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Electronics retailer Best Buy Co. Inc. (BBY), has announced it will retail Apple Watch in its store from next month, making it the first retailer besides Apple Stores to offer the smartwatch that was launched three months ago. Initially, Best Buy will start selling the smartwatch in over 100 stores... Here is a quick summary of the earnings reported after the bell on Jul 27. 1.Del Taco Restaurants, Inc. (TACO, TACOW) Q2 Net income was $4.6 million compared to net loss of $0.1 million a year ago. Q2 Total revenue was $97.6 million, an increase of 7.0% compared to $91.2 million a year ago. *** 2.Plantronics,...
comments powered by Disqus
Follow RTT